Market Tracker

07/23 6:05pm ET

Merck & Co Inc (NYSE:MRK)

During the Trading Day
58.11 -0.32 / -0.55%
Data as of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
58.11 0.00 / 0.00%
 
Volume: 70.5K
Stock Market News for July 23, 2014 - Market News
10:57am / Zacks.com
Eli Lilly joins forces with UK biotech to develop cancer drugs
Jul 16 / FT.com
GSK cuts guidance as sales and profits slide
8:22am / FT.com
2 Reasons to Watch Bristol-Myers Squibb Co
Jul 15 / MotleyFool.com
3 Stocks Reiterated As A Buy: MDLZ, MRK, IBM
Jul 22 / TheStreet.com
1 Hidden Blockbuster Lurking in Merck's Pipeline?
Jul 14 / MotleyFool.com
3 Things You Need to Watch on Gilead Sciences Inc. Earnings Call
Jul 22 / MotleyFool.com
Johnson & Johnson Earnings: Can Pharma Keep Stoking Growth?
Jul 14 / MotleyFool.com
These 3 Dow Stocks Might be Too Richly Valued for You
Jul 21 / MotleyFool.com
Bristol-Myers to Seek U.S. Approval for Immuno-Oncology Drug - Analyst Blog
Jul 11 / Zacks.com
ABBV, MRK And PFE, Pushing Health Care Sector Downward
Jul 21 / TheStreet.com
1 Drug More Important to Gilead Than Sovaldi
Jul 11 / MotleyFool.com
How the Dow's Pharma Stocks Helped Boost Markets Friday
Jul 18 / MotleyFool.com
Is This MannKind's Greatest Risk?
Jul 11 / MotleyFool.com
Technology: Wear your medicine
Jul 18 / FT.com
Jounce Taps Merck Vet to Lead Cancer Drug Push
Jul 10 / MotleyFool.com
3 Stocks Reiterated As A Buy: MU, MRK, MET
Jul 18 / TheStreet.com
Is This High-Yielding ETF Right For Your Portfolio?
Jul 09 / MotleyFool.com
Cramer: The Tell of When to Sell
Jul 17 / TheStreet.com
Low volatility is bad for 'low-vol' funds
Jul 09 / FT.com
Roche Gets Priority Review for Avastin Label Expansion - Analyst Blog
Jul 16 / Zacks.com
Venezuela is wreaking havoc on big companies
Jul 09 / CNNMoney.com
Jim Cramer's Stop Trading: Speculation Isn't Bad
Jul 16 / TheStreet.com